Credit Agricole’s Meridian Bioscience Inc VIVO Stock Holding History

Credit Agricole’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-69	Closed	-$2.29K	–	769
2022 Q4	$2.29K	Hold	69	–	–	﹤0.01%	664
2022 Q3	$2K	Hold	69	–	–	﹤0.01%	659
2022 Q2	$2K	Hold	69	–	–	﹤0.01%	661
2022 Q1	$2K	Buy	+69	New	+$1.64K	﹤0.01%	685
2017 Q2	–	Sell	-20,015	Closed	-$2.06M	–	1631
2017 Q1	$2.06M	Buy	+20,015	New	+$280K	0.01%	984

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Credit Agricole's VIVO Position: Q1 2023 in Review

Credit Agricole sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 69 shares — an estimated $2.29K sold.

Credit Agricole first reported a position in VIVO in Q1 2017 and held it in 5 quarters. The position peaked at $2.06M in Q1 2017. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Credit Agricole reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Credit Agricole sold 69 Meridian Bioscience Inc shares in Q1 2023, an estimated $2.29K.
Credit Agricole first reported a position in Meridian Bioscience Inc in Q1 2017 and held it in 5 quarters.
Credit Agricole's Meridian Bioscience Inc position peaked at $2.06M in Q1 2017.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Credit Agricole's 13F filing for Q1 2023, filed 15 May 2023.